The HemOnc Pulse
Latest Episodes
Mazyar Shadman, MD, MPH, Reports the Latest BTKi News in CLL
Dr. Shadman of the Fred Hutchinson Cancer Center
Bhavana Bhatnagar, MD, on the Molecular Revolution in AML
In this episode of The HemOnc Pulse, Dr. Bhatnaga
Do Venetoclax Combinations Trump Chemotherapy in Frontline CLL Treatment?
Is there a venetoclax combination that reigns sup
Why Grzegorz Nowakowski, MD, Says There’s a ‘Revolution’ in LBCL Therapy
Dr. Nowakowski, a Professor of Oncology and Medic
An Expert's Look into the World of Rare Blood Cancers
Naveen Pemmaraju, MD, Associate Professor at the
The Logistics of CAR-T in Hematologic Malignancies
Navneet Majhail, MD, MS, the Physician in Chief a
Abi Vijenthira, MD, and Anca Prica, MD, on Why Certain DLBCL Therapies May Not Be Cost Effective
Drs. Vijenthira and Prica, both of the Princess M
Sagar Lonial, MD, FACP, on Why This MRD Approach Is 'Premature' in MM
Blood Cancers Today Editor-in-Chief Sagar Lonial,
Alan Skarbnik, MD, Gives the Lowdown on Treating Patients with Follicular Lymphoma
Alan Skarbnik, MD, of Novant Health, discusses tr
Amer Zeidan, MBBS, MHS, on the Evolution of AML Classification, Treatment
In this episode of The HemOnc Pulse, Amer Zeidan,